Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study - ScienceDirect
Efficacy and safety of once-monthly Risperidone ISM® in schizophrenic patients with an acute exacerbation | Schizophrenia
Classics in Chemical Neuroscience: Risperidone | ACS Chemical Neuroscience
Risperdal Recall, FDA Warnings & Side Effects - Recall Guide
MedsOnCue OnDemand - Risperidone
Population Pharmacokinetic Modeling and Simulation of TV‐46000: A Long‐Acting Injectable Formulation of Risperidone - Perlstein - - Clinical Pharmacology in Drug Development - Wiley Online Library